OASIS-3: Longitudinal Neuroimaging, Clinical, and Cognitive Dataset for Normal Aging and Alzheimer Disease

ABSTRACT OASIS-3 is a compilation of MRI and PET imaging and related clinical data for 1098 participants who were collected across several ongoing studies in the Washington University Knight Alzheimer Disease Research Center over the course of 15 years. Participants include 605 cognitively normal adults and 493 individuals at various stages of cognitive decline ranging in age from 42 to 95 years. The OASIS-3 dataset contains over 2000 MR sessions, including multiple structural and functional sequences. PET metabolic and amyloid imaging includes over 1500 raw imaging scans and the accompanying post-processed files from the PET Unified Pipeline (PUP) are also available in OASIS-3. OASIS-3 also contains…

• EL
  Eli Lilly and Company
• NI
  National Institutes of Health

  Awards: UL1TR000448, P50AG00561, R01AG043434, P30NS09857781, P01AG003991, P01AG026276, R01EB009352
• AR
  Avid Radiopharmaceuticals
• CF
  Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University in St. Louis

  Award: P01AG003991